Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 449

1.

Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study.

Jacobs-van der Bruggen MA, Bos G, Bemelmans WJ, Hoogenveen RT, Vijgen SM, Baan CA.

Diabetes Care. 2007 Jan;30(1):128-34.

PMID:
17192345
2.

Cost effectiveness of community-based physical activity interventions.

Roux L, Pratt M, Tengs TO, Yore MM, Yanagawa TL, Van Den Bos J, Rutt C, Brownson RC, Powell KE, Heath G, Kohl HW 3rd, Teutsch S, Cawley J, Lee IM, West L, Buchner DM.

Am J Prev Med. 2008 Dec;35(6):578-88. doi: 10.1016/j.amepre.2008.06.040.

PMID:
19000846
3.

An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes.

Ackermann RT, Marrero DG, Hicks KA, Hoerger TJ, Sorensen S, Zhang P, Engelgau MM, Ratner RE, Herman WH.

Diabetes Care. 2006 Jun;29(6):1237-41.

PMID:
16732002
4.

Effects of lifestyle intervention on health care costs: Improving Control with Activity and Nutrition (ICAN).

Wolf AM, Siadaty M, Yaeger B, Conaway MR, Crowther JQ, Nadler JL, Bovbjerg VE.

J Am Diet Assoc. 2007 Aug;107(8):1365-73.

PMID:
17659904
5.

Cost-effectiveness of lifestyle modification in diabetic patients.

Jacobs-van der Bruggen MA, van Baal PH, Hoogenveen RT, Feenstra TL, Briggs AH, Lawson K, Feskens EJ, Baan CA.

Diabetes Care. 2009 Aug;32(8):1453-8. doi: 10.2337/dc09-0363.

6.

Cost-effectiveness of diabetes self-management programs in community primary care settings.

Brownson CA, Hoerger TJ, Fisher EB, Kilpatrick KE.

Diabetes Educ. 2009 Sep-Oct;35(5):761-9. doi: 10.1177/0145721709340931.

PMID:
19622716
7.

The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action.

Bemelmans W, van Baal P, Wendel-Vos W, Schuit J, Feskens E, Ament A, Hoogenveen R.

Prev Med. 2008 Feb;46(2):127-32.

PMID:
17822752
8.

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Engelgau MM.

Diabetes Care. 2007 Nov;30(11):2874-9.

PMID:
17698614
9.

Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care.

Bertram MY, Lim SS, Barendregt JJ, Vos T.

Diabetologia. 2010 May;53(5):875-81. doi: 10.1007/s00125-010-1661-8.

PMID:
20135088
10.

Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a 'real world' routine healthcare setting: model based on the KORA Survey 2000.

Icks A, Rathmann W, Haastert B, Gandjour A, Holle R, John J, Giani G; KORA Study Group..

Diabet Med. 2007 May;24(5):473-80.

PMID:
17381502
11.

The European perspective of type 2 diabetes prevention: diabetes in Europe--prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.

Schwarz PE, Lindström J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M, Tuomilehto J; DE-PLAN project..

Exp Clin Endocrinol Diabetes. 2008 Mar;116(3):167-72. doi: 10.1055/s-2007-992115.

PMID:
18350480
12.
13.

Lifestyle intervention to prevent diabetes: intensive and cost effective.

Wylie-Rosett J, Herman WH, Goldberg RB.

Curr Opin Lipidol. 2006 Feb;17(1):37-44.

PMID:
16407714
14.

Cost-effectiveness of interventions promoting physical activity.

Müller-Riemenschneider F, Reinhold T, Willich SN.

Br J Sports Med. 2009 Jan;43(1):70-6. doi: 10.1136/bjsm.2008.053728. Review.

PMID:
18971249
15.

Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy.

Schwarz B, Gouveia M, Chen J, Nocea G, Jameson K, Cook J, Krishnarajah G, Alemao E, Yin D, Sintonen H.

Diabetes Obes Metab. 2008 Jun;10 Suppl 1:43-55. doi: 10.1111/j.1463-1326.2008.00886.x.

PMID:
18435673
17.
18.

Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

Eddy DM, Schlessinger L, Kahn R.

Ann Intern Med. 2005 Aug 16;143(4):251-64.

PMID:
16103469
20.

A cost-effectiveness analysis of a community-based diabetes prevention program in Sweden.

Johansson P, Ostenson CG, Hilding AM, Andersson C, Rehnberg C, Tillgren P.

Int J Technol Assess Health Care. 2009 Jul;25(3):350-8. doi: 10.1017/S0266462309990079.

PMID:
19619354
Items per page

Supplemental Content

Support Center